AMH与PCOS不孕患者有无排卵的相关性分析

doi:10.3969/j.issn.1671-7171.2016.11.011

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1271 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To analyze the relationship between Anti-Mullerian hormone (AMH) and polycystic ovary syndrome (PCOS) in infertile patients with ovulation. 【Methods】A total of 50 cases of patients with PCOS were observed. At the same time, 50 healthy adult women were selected as the control group. The levels of AMH, FSH and LH were detected in the two groups. The differences in AMH levels in follicular fluid between the two groups were compared as well. Further the levels of AMH, FSH and LH were observed in PCOS patients with and without ovulation. 【Results】In the PCOS group, the serum levels of AMH and FSH were significantly higher than those of the control group, while the level of LH was significantly higher than the control group; the difference was statistically significant (P<0.05). M2 follicular fluid AMH and FSH levels were significantly higher than M1 follicular fluid levels, while LH level was significantly lower than that of M1 follicular fluid, and the difference was statistically significant (P<0.05). The levels of AMH and FSH were significantly lower in the PCOS infertility group without ovulation than those in the PCOS infertility patients with ovulation, while the LH level was significantly higher in the patients with ovulation; the difference was statistically significant (P<0.05). 【Conclusion】The level of AMH in patients with PCOS infertility is high, and the AMH level of PCOS patients without ovulation is even higher. This can be used as an indicator for clinical monitoring of PCOS infertility patients with ovulation.

Key words： Anti-Mullerian Hormone Polycystic Ovary Syndrome Infertility, Female Ovulation

Received: 14 April 2016

PACS:

R711.6

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Xiao-li
	XUE Juan

Cite this article:

LI Xiao-li,XUE Juan. Study on the Relationship Between AMH and PCOS in Infertile Patients with Ovulation[J]. JOURNAL OF CLINICAL RESEARCH, 2016, 33(11): 2113-2115.

URL:

http://www.jcr.net.cn/EN/10.3969/j.issn.1671-7171.2016.11.011 OR http://www.jcr.net.cn/EN/Y2016/V33/I11/2113

[1] 李青青. 二甲双胍联合炔雌醇环丙孕酮治疗多囊卵巢综合征不孕症的临床观察[J].现代仪器与医疗,2015,21(2):103-104.
[2] 何雪梅,李萍,沙艳伟,等. 闽西南地区多囊卵巢综合征患者临床干预前、后血清抗苗勒管激素变化研究[J].生殖与避孕,2015,24(8):579-582.
[3] 何艺磊,陈君逸,李蓉. 多囊卵巢综合征患者IVF-ET中卵巢过度刺激综合征相关影响因素[J].中国妇产科临床杂志,2015,30(6):565-567.
[4] 贾新转,魏兰. 阿托伐他汀治疗多囊卵巢综合征与患者25-羟维生素D水平的关系[J].中国现代医学杂志,2015,34(29):70-72.
[5] Tian X, Ruan X, Mueck AO,et al. Anti-Mullerian hormone levels in women with polycystic ovarian syndrome compared with normal women of reproductive age in China[J].Gynecol Endocrinol,2014,30(2):126-129.
[6] 林伟,董磊. 黄体生成素受体及类固醇激素合成急性调节蛋白在大鼠多囊卵巢综合征模型中的表达[J].生殖与避孕,2016,24(1):9-14.
[7] 刘颖华,侯丽辉,徐芳. 青春期多囊卵巢综合征流行病学研究进展[J].实用医学杂志,2015,34(20):3440-3441.
[8] 韦娟冰. 来曲唑用于多囊卵巢综合征患者促排卵的临床疗效及安全性评价[J].中国临床药理学杂志,2015,40(19):1928-1930.
[9] 徐文迪,陶弢,刘伟. 多囊卵巢综合征代谢异常治疗新进展[J].上海交通大学学报(医学版),2015,34(9):1407-1413.
[10] Saleh BO, Ibraheem WF, Ameen NS. The role of anti-Mullerian hormone and inhibin B in the assessment of metformin therapy in women with polycystic ovarian syndrome[J].Saudi Med J,2015,36(5):562-567.
[11] Tian X, Ruan X, Mueck AO, et al. Serum anti-Mullerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China[J].Gynecol Endocrinol,2014,30(11):836-839.
[12] 许文琼,黄海华,甘华侠,等. 新诊断多囊卵巢综合征患者Nesfatin-1水平变化及相关因素研究[J].中国现代医学杂志,2015,42(35):66-69.
[13] 杨诗源,阮洁,黄薇,等. 血清抗苗勒管激素水平在基于2012年中国多囊卵巢综合征诊断标准患者中的初步研究[J].中华妇产科杂志,2015,50(11):819-824.
[14] Zadehmodarres S, Heidar Z, Razzaghi Z, et al. Anti-mullerian hormon level and polycystic ovarian syndrome diagnosis[J].Iran J Reprod Med,2015,13(4):227-230.
[15] 赵越,阮祥燕,崔亚美,等. 不同亚型的多囊卵巢综合征患者临床及实验室指标特征的研究[J].首都医科大学学报,2015,36(04):567-572.

[1]	. [J]. JOURNAL OF CLINICAL RESEARCH, 2016, 33(12): 2463-2466.